Drug utilisation and health outcomes of pharmacotherapy

We are a transversal group, we have a wide knowledge and training in relation to pharmacotherapy with a high complexity and specialization. We are experts in the safe and effective use of medicines, applying efficiency and innovation criteria. On the other hand, being a central service, we have experience in process management.

Our clinical areas with greater presence of pharmacists are: elderly patient (geriatrics), infectious (HIV, HCV, HBV, HBV, PROA), hematology, rheumatology, dermatology, neurology and emergency. We offer:

  • Pharmacovigilance, medication safety experience.
  • Knowledge and availability of medications.
  • Data on the use and consumption of medicines.
  • Preparation of drug preparations.
  • Clean rooms.
  • Drug-related technologies.
  • Structure for the management and development of Clinical Trials.
  • Quality Management System Certification.

Search for publications

Only original articles, editorials, guidelines.

  • Hernández-García M, Nieto-Torres M, Guerra-Pinto N, Castillo-Polo JA, Saez de la Fuente J, Michelena M, Ponce-Alonso M, Soriano-Cuesta C, Díaz-Agero C, Cantón R, Coque TM, Ruiz-Garbajosa P.

    ICU environment as a reservoir of KPC-ST307-Klebsiella pneumoniae high-risk clone resistant to ceftazidime-avibactam

    Scientific Reports . 15(1): 29486-29486. Number of citations: 6

    [doi:10.1038/s41598-025-14987-w]

  • Esteban-Cartelle B, Anaya BJ, Pérez Menéndez-Conde C, Vicente-Oliveros N, Serrano DR, Álvarez-Díaz A, Fortún-Abete J, Martín-Dávila P.

    Stability of Ceftobiprole Medocaril in Portable Elastomeric Infusion Devices

    Infectious Diseases and Therapy . 14(8): 1685-1696. Number of citations: 2

    [doi:10.1007/s40121-025-01174-7]

  • Máiz L, Nieto R, Durán D, Máiz J, Ruiz-Calvo G, Muriel A, Barbero E, Vélez-Díaz-Pallarés M, Morillo R.

    Short-term Tolerance to Inhaled Antibiotics in Patients With Bronchial Infection not Associated With Cystic Fibrosis.

    Open Respiratory Archives . 7(3): 100460-100460.

    [doi:10.1016/j.opresp.2025.100460]

  • Fortún J, Rodríguez-Gandía MA, Pintado V, Martín-Dávila P, García-González M, Graus J, Martín-Mateos R, Fuente JS, Muriel A, Moreno S.

    Oral nonabsorbable antibiotics for prevention of recurrent cholangitis; a brief report study

    INFECTION . 53(3): 1219-1225. Number of citations: 1

    [doi:10.1007/s15010-025-02491-2]

  • Alonso-Gordoa T, Anguera G, Domínguez-Esteban M, Reig Ò, Martínez-Barros H, Molina-Cerrillo J, Cruz P, Maroto P.

    Expert consensus on patterns of progression in kidney cancer after adjuvant immunotherapy and subsequent treatment strategies.

    CANCER TREATMENT REVIEWS . 136: 102925-102925. Number of citations: 3

    [doi:10.1016/j.ctrv.2025.102925]

  • Rosas Cancio-Suárez M, Moreno A, del Campo Terrón S, Vivancos MJ, G García-Ruiz De Morales A, Martínez-Sanz J, Ron R, Sánchez-Izquierdo S, Vélez-Díaz-Pallarés M, Moreno S, Pérez-Elías MJ.

    Real-world efficacy and tolerability of CAB plus RPV LA in women: addressing the gender gap in HIV treatment research

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 80(4): 1084-1088. Number of citations: 2

    [doi:10.1093/jac/dkaf038]

  • Buti M, Calleja JL, Rodríguez MÁ, Domínguez-Hernández R, Cantero H, Espinoza-Cámac N, Casado MÁ.

    Clinical and economic value of bulevirtide in the treatment of chronic hepatitis D

    Gastroenterologia y Hepatologia . 48(3): 502241-502241. Number of citations: 7

    [doi:10.1016/j.gastrohep.2024.502241]

  • Rodríguez Sagrado MA, Alvarez Criado J, Arenaza Peña AE, Escudero-Vilaplana V, Folguera Olias C, Herrero Fernandez M, Martinez Nieto C, Rubio Salvador AR, Sanmartin Fenollera P, Vazquez Castillo MJ.

    Niraparib Maintenance Therapy in Patients with Platinum-Sensitive Recurrent Ovarian Cancer: Real-World Experience at Hospitals in Spain

    Targeted Oncology . 20(2): 319-327.

    [doi:10.1007/s11523-024-01121-5]

  • Morillo Verdugo R, Bernardez Ferrán B, Fernández Polo A, Margusino Framiñan L, Martínez Sesmero JM, Velez-Diaz-Pallarés M, Vicente-Escrig E.

    Prioritization of initiatives 2024-2027 of the strategic map of pharmaceutical outpatient care of the Spanish Society of Hospital Pharmacy

    FARMACIA HOSPITALARIA . 49(1): 3-10. Number of citations: 2

    [doi:10.1016/j.farma.2024.03.013]

  • Verdugo RM, Ferrán BB, Polo AF, Framiñan LM, Sesmero JMM, Velez-Diaz-Pallarés M, Vicente-Escrig E.

    [Translated article] Prioritisation of 2024-2027 initiatives of the strategic Map for outpatient pharmaceutical care of the Spanish Society of Hospital Pharmacy

    FARMACIA HOSPITALARIA . 49(1): 3-10. Number of citations: 3

    [doi:10.1016/j.farma.2024.08.003]

  • Montero-Llorente B, Pérez Menéndez-Conde C, González Ferrer E, López Castellanos GT, Bedoya Del Olmo LM, Bermejo Vicedo T.

    Impact of pharmaceutical care on hospital readmissions for heart failure: a randomised trial.

    European Journal of Hospital Pharmacy . : .

    [doi:10.1136/ejhpharm-2024-004218]

  • Martínez-Barros H, Pousada-Fonseca Á, Pedreira-Bouzas J, Clopés-Estela A.

    Characteristics, clinical benefit and reimbursement of new authorisations for oncohaematology drugs in Spain between 2017 and 2020.

    FARMACIA HOSPITALARIA . 48(6): 272-277. Number of citations: 1

    [doi:10.1016/j.farma.2024.04.022]

  • Martínez-Barros H, Pousada-Fonseca Á, Pedreira-Bouzas J, Clopés-Estela A.

    [Translated article] Characteristics, clinical benefit, and reimbursement of new authorisations for oncohaematology drugs in Spain between 2017 and 2020.

    FARMACIA HOSPITALARIA . 48(6): 272-277. Number of citations: 1

    [doi:10.1016/j.farma.2024.07.006]

  • PARRO MARTÍN, MARÍA DE LOS ÁNGELES.

    Guide for the efficient and safe delivery of Telepharmacy

    Health Policy and Technology . : .

    [doi:https://doi.org/10.1016/j.hlpt.2024.100899]

  • Fernández de Gamarra-Martínez E, Tortajada-Goitia B, Corte-García JJ, Martín-Herranz I, García-Gil M, Sáez de la Fuente J, Nicolás-Picó J.

    Hospital pharmacy towards 2030.

    FARMACIA HOSPITALARIA . 48 Suppl 1: 52-58.

    [doi:10.1016/j.farma.2024.05.004]

  • Fernández de Gamarra-Martínez E, Tortajada-Goitia B, Corte-García JJ, Martín-Herranz I, García-Gil M, Sáez de la Fuente J, Nicolás-Picó J.

    [Translated article] Hospital pharmacy towards 2030.

    FARMACIA HOSPITALARIA . 48 Suppl 1: 52-58. Number of citations: 1

    [doi:10.1016/j.farma.2024.06.008]

  • Fernández-Fradejas J, Delgado-Silveira E, González-Burgos E, Álvarez-Díaz AM, Vélez-Díaz-Pallarés M.

    Potentially inappropriate prescriptions and potential prescription omissions in older people living with HIV.

    HIV MEDICINE . 25(5): 587-599. Number of citations: 5

    [doi:10.1111/hiv.13616]

  • Meijon-Ortigueira MDM, Solares I, Muñoz-Delgado C, Stanescu S, Morado M, Pascual-Izquierdo C, Villalon Blanco L, Belanger Quintana A, Menéndez-Conde CP, Morales-Conejo M, Villarrubia-Espinosa J.

    Women with Gaucher Disease.

    Biomedicines . 12(3): . Number of citations: 8

    [doi:10.3390/biomedicines12030579]